Consumer medicine information

Pethidine Juno Injection

Pethidine hydrochloride

BRAND INFORMATION

Brand name

Pethidine Juno

Active ingredient

Pethidine hydrochloride

Schedule

S8

 

Consumer medicine information (CMI) leaflet

Please read this leaflet carefully before you start using Pethidine Juno Injection.

Pethidine Juno Injection

Pethidine Juno Injection


 Consumer Medicine Information (CMI) summary

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist.


WARNING: Important safety information is provided in a boxed warning in the full CMI. Read before using this medicine.

 1. Why am I being treated with Pethidine Juno?

Pethidine Juno contains the active ingredient pethidine hydrochloride. Pethidine is pain killer that belongs to a group of medicines called opioid analgesics. It is most commonly used to relieve severe pain. It may also be used just before, or during, an operation, to help the anaesthetic work better.

For more information, see Section 1. Why am I being treated with Pethidine Juno? in the full CMI.

 2. What should I know before treatment with Pethidine Juno?

Do not use if you have ever had an allergic reaction to pethidine or any of the ingredients listed at the end of the CMI.

Talk to your doctor if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant or are breastfeeding.

For more information, see Section 2. What should I know before treatment with Pethidine Juno? in the full CMI.

 3. What if I am taking other medicines?

Some medicines may interfere with pethidine and affect how it works.

A list of these medicines is in Section 3. What if I am taking other medicines? in the full CMI.

 4. How is Pethidine Juno given?

Your doctor will decide what dose of pethidine you will receive. This depends on your condition and other factors, such as your age and weight.

More instructions can be found in Section 4. How is Pethidine Juno given? in the full CMI.

 5. What should I know during treatment with Pethidine Juno?

Things you should do
  • Remind any doctor, dentist or pharmacist you visit that you are being given pethidine.
  • If you become pregnant while you are being treated with pethidine, tell your doctor immediately.
Things you should not do
  • Do not stop using this medicine suddenly. If you have been using pethidine for more than two weeks, you may experience unpleasant feelings if you stop pethidine suddenly.
Driving or using machines
  • Do not drive a car, operate machinery, or do anything else that could be dangerous until you know how pethidine affects you. Pethidine may cause drowsiness and impair coordination.
Drinking alcohol
  • Do not drink alcohol while you are being treated with pethidine.
Looking after your medicine
  • If you are being given Pethidine Juno while in hospital, it will be stored in the pharmacy or on the ward. Store below 25°C.

For more information, see Section 5. What should I know during treatment with Pethidine Juno? in the full CMI.

 6. Are there any side effects?

Common side effects are mild and usually short lived. These include drowsiness, dizziness or unsteadiness, light-headedness, sweating or flushing, nausea or vomiting, constipation, hallucinations, pain and irritation at the injection site, blurred vision, dry mouth and mood changes. If you experience serious side effects such as severe drowsiness, slow or rapid heart beat, difficulty in urinating, slow or troubled breathing, severe weakness, agitation, twitching, jerking, seizures (fits), or unconsciousness, you may need urgent medical attention or hospitalisation.

For more information, including what to do if you have any side effects, see Section 6. Are there any side effects? in the full CMI.


WARNING:

Limitations of use

Because of the risks associated with the use of opioids, pethidine should only be used when your doctor decides that other treatment options are not able to effectively manage your pain or you cannot tolerate them.

Hazardous and harmful use

Pethidine poses risks of abuse, misuse and addiction which can lead to overdose and death. Your doctor will monitor you regularly during treatment.

Life threatening respiratory depression

Pethidine can cause life-threatening or fatal breathing problems (slow, shallow, unusual or no breathing), even when used as recommended. These problems can occur at any time during use, but the risk is higher when first starting pethidine, after a dose increase, if you are older, or have an existing problem with your lungs. Your doctor will monitor you and change the dose as appropriate.

Use of benzodiazepines and other central nervous system (CNS) depressants, including alcohol

Using pethidine with other medicines that can make you feel drowsy such as sleeping tablets (e.g. benzodiazepines), other pain relievers, antihistamines, antidepressants, antipsychotics, gabapentinoids (e.g. gabapentin and pregabalin), cannabis and alcohol may result in severe drowsiness, decreased awareness, breathing problems, coma and death. Your doctor will minimize the dose and duration of use; and monitor you for signs and symptoms of breathing difficulties and sedation. You must not drink alcohol while using pethidine.

Pethidine Juno Injection

Active ingredient(s): pethidine hydrochloride


 Consumer Medicine Information (CMI)

This leaflet provides important information about using Pethidine Juno. You should also speak to your doctor or pharmacist if you would like further information or if you have any concerns or questions about using Pethidine Juno.

Where to find information in this leaflet:

1. Why am I being treated with Pethidine Juno?
2. What should I know before treatment with Pethidine Juno?
3. What if I am taking other medicines?
4. How is Pethidine Juno given?
5. What should I know during treatment with Pethidine Juno?
6. Are there any side effects?
7. Product details

1. Why am I being treated with Pethidine Juno?

Pethidine Juno contains the active ingredient pethidine hydrochloride. Pethidine is a pain killer that belongs to a group of medicines called opioid analgesics. Pethidine acts in the brain and the spinal cord.

Pethidine Juno is most commonly used for the short-term management of severe pain. It may also be used just before, or during, an operation, to help the anaesthetic work better.

Your doctor may have prescribed pethidine for another reason.

Ask your doctor if you have any questions about why pethidine has been prescribed for you.

2. What should I know before treatment with Pethidine Juno?

If you are not sure whether you should start treatment with pethidine, talk to your doctor or pharmacist.

Warnings

Do not use Pethidine Juno if you:

  • are allergic to pethidine, or any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include:
    - shortness of breath, wheezing or difficulty breathing
    - swelling of the face, lips, tongue or other parts of the body,
    - rash, itching or hives on the skin
    Always check the ingredients to make sure you can use this medicine.
  • are an asthmatic, have breathing problems or have severe disease relating to the lungs
  • are suffering from a head injury or brain tumour
  • are suffering from a convulsive state such as status epileptics or tetanus, or if you have eclampsia or pre-eclampsia.
  • have an irregular heart beat (arrhythmia)
  • have diabetic acidosis
  • are undergoing treatment with, or have finished treatment in the last two weeks with, monoamine oxidase (MAO) inhibitors (e.g. selegiline, phenelzine, tranylcypromine, moclobemide)
  • have severe liver or kidney disease
  • have blood-coagulation problems, or are receiving treatment for this disorder (e.g. warfarin)
  • are suffering from acute alcoholism
  • have a blockage in the stomach and intestine (severe constipation) or have severe pain in the stomach with bloating, gut cramps and vomiting (paralytic ileus).

Check with your doctor if you:

  • have or have had any other medical conditions, especially the following:
    - lung or breathing problems
    - drug or alcohol abuse
    - a history of mental illness
    - gall bladder disease or gallstones
    - under-active thyroid (hypothyroidism)
    - adrenal gland tumour (phaechromocytoma) and/or when the adrenal glands are not working properly (Addison's disease)
    - diabetes
    - epilepsy, convulsions, fits or seizures, or head injuries
    - glaucoma (increased pressure in the eye)
    - heart problems
    - liver or kidney impairment
    - severe inflammatory bowel disease or biliary colic
    - snoring or sleep apnoea (you temporarily stop breathing or have difficulty breathing while asleep)
  • take any medicines for any other condition
  • have allergies to any other medicines, foods, preservatives or dyes.

During treatment, you may be at risk of developing certain side effects. It is important you understand these risks and how to monitor for them. See additional information under Section 6. Are there any side effects?

Pregnancy and breastfeeding

Check with your doctor if you are pregnant or intend to become pregnant.

Your doctor will discuss the possible risks and benefits of you being given pethidine during pregnancy.

Talk to your doctor if you are breastfeeding or intend to breastfeed.

Your doctor will discuss the possible risks and benefits of you being given pethidine during breastfeeding.

Addiction

You can become addicted to pethidine even if you use it exactly as prescribed. Pethidine may become habit forming causing mental and physical dependence. If abused it may become less able to reduce pain.

Dependence

As with all other opioid containing products, your body may become used to you using pethidine. Using it for a long time (i.e. more than two weeks) may result in physical dependence. Physical dependence means that you may experience withdrawal symptoms if you stop using pethidine suddenly, so it is important to use it exactly as directed by your doctor.

However, it is also important to keep your pain under control.

Your doctor can advise you on how to prevent and manage this.

Tolerance

Tolerance to pethidine may develop, which means that the effect of the medicine may decrease. If this happens, more may be needed to maintain the same effect.

Withdrawal

Continue using your medicine for as long as your doctor tells you. If you stop using this medicine suddenly, your pain may worsen and you may experience some or all of the following withdrawal symptoms:

  • nervousness, restlessness, agitation, trouble sleeping or anxiety
  • body aches, weakness or stomach cramps
  • loss of appetite, nausea, vomiting or diarrhoea
  • increased heart rate, breathing rate or pupil size
  • watery eyes, runny nose, chills or yawning
  • increased sweating.

Pethidine given to the mother during labour can cause breathing problems and signs of withdrawal in the newborn.

3. What if I am taking other medicines?

Tell your doctor or pharmacist if you are taking any other medicines, including any medicines, vitamins or supplements that you buy without a prescription from your pharmacy, supermarket or health food shop.

Some medicines may interfere with pethidine and affect how it works. These include:

  • antidepressants or medicines for anxiety disorders, such as:
    - selective serotonin reuptake inhibitors (SSRIs)
    - serotonin and norepinephrine reuptake inhibitors (SNRIs)
    - tricyclic antidepressants (TCAs)
    - monoamine oxidase inhibitors (MAOIs) e.g. moclobemide, phenelzine, tranylcypromine
  • medicines used for migraines (triptans)
  • medicines used to prevent or treat nausea and vomiting (5-HT3 receptor antagonists)
  • selegiline, a monoamine oxidase inhibitor used to treat Parkinson's disease
  • warfarin, a medicine used to prevent blood clots
  • phenytoin or phenobarbital, medicines used to control fits or seizures
  • other medicines which may make you drowsy such as sleeping tablets (e.g. benzodiazepines, hypnotics), tablets to calm your nerves (e.g. sedatives), muscle relaxants, medicines to treat mental disorders, other opioid analgesics or strong painkillers, some antihistamines.
  • amphetamines
  • cimetidine, a medicine used to treat stomach ulcers and gastric reflux.

Medicines that may increase the effect of pethidine include:

  • macrolide antibiotics (e.g. erythromycin)
  • azole-antifungal agents (e.g. ketoconizole)
  • protease inhibitors or medication for HIV (e.g. ritonavir).

Medicines that may reduce the effect of pethidine include:

  • rifampicin (anti-tuberculosis medication)
  • carbamazepine and phenytoin (medicines used to control fits or seizures).

Your doctor will minimise the dose and duration of use; and monitor you for signs and symptoms of breathing difficulties and sedation.

These medicines may be affected by pethidine, or may affect how well it works. You may need different amounts of your medicine, or you may need to take/use different medicines. Your doctor or pharmacist will advise you.

Your doctor and pharmacist have more information on medicines to be careful with or avoid while you are receiving Pethidine Juno.

Check with your doctor or pharmacist if you are not sure about what medicines, vitamins or supplements you are taking and if these affect Pethidine Juno.

4. How is Pethidine Juno given?

How much is given

Your doctor will decide what dose of pethidine you will receive. This depends on your condition and other factors, such as your age and weight.

How it is given

Your doctor or nurse will usually administer Pethidine Juno Injection.

Pethidine Juno can be given as:

  • an injection into a muscle
  • a slow injection into a vein
  • an injection under the skin or
  • by a method called patient-controlled analgesia:
    - This method allows you, the patient, to control the amount of pethidine you wish to receive. On experiencing pain, you can press a button which allows a dose of pethidine to be administered to you. To prevent you receiving too much pethidine, there is a "lockout" period built into the pump which prevents continuous injection of pethidine.

Your doctor will decide the appropriate way for you to be given pethidine.

If you use too much (overdose)

Pethidine Juno is only recommended to be given for a maximum of 24 to 36 hours, however some people may need to receive it for longer.

If you or someone else have received too much (overdose) Pethidine Juno and experience one or more of the symptoms below, urgent medical attention is required. Keep the person awake by talking to them or gently shaking them every now and then. You should follow the above steps even if someone other than you have accidentally been given pethidine that was prescribed for you.

Symptoms of an overdose may include:

  • slow, unusual or difficult breathing
  • severe drowsiness, dizziness or unconsciousness
  • slow or weak heartbeat
  • nausea or vomiting
  • convulsions or fits (twitching or jerking)
  • severe weakness
  • pale and cold skin.

You should immediately:

  • phone the Poisons Information Centre
    (by calling 13 11 26), or
  • contact your doctor, or
  • go to the Emergency Department at your nearest hospital.

When seeking medical attention, take this leaflet and remaining medicine with you to show the doctor. Also tell them about any other medicines or alcohol which have been taken.

You should do this even if there are no signs of discomfort or poisoning.

5. What should I know during treatment with Pethidine Juno?

As pethidine may cause nausea and vomiting, your doctor is likely to prescribe medicine for you to take/receive before the pethidine, to stop you feeling sick.

Pethidine may also cause constipation, so your doctor is likely to prescribe laxatives to prevent this happening.

Things you should do

  • Tell any doctors, dentists and pharmacists who are treating you that you are being given Pethidine Juno.
  • If you are about to be started on any new medicine, tell your doctor, dentist and pharmacist that you are being given Pethidine Juno.
  • If you plan to have surgery that needs a general anaesthetic, tell your doctor or dentist that you are being treated with Pethidine Juno.
  • If you become pregnant while you are being treated with pethidine, tell your doctor or pharmacist.
  • Tell your doctor, pharmacist or nurse if you have any concerns about being given pethidine.

Things you should not do

  • Do not give Pethidine Juno to anyone else, even if they have the same condition as you.
  • Do not use Pethidine Juno to treat any other complaints unless your doctor or pharmacist tells you to.
  • Do not stop using Pethidine Juno or lower the dosage without checking with your doctor or pharmacist. If you have been using pethidine for more than two weeks, you may experience unpleasant feelings if you stop it suddenly. Your doctor will probably want you to gradually reduce the amount of pethidine you are using, before stopping it completely.
  • Do not take any other medicines, whether they are prescription or over-the-counter medicines, unless they have been prescribed or recommended by a doctor or pharmacist who knows you are being given pethidine.

Driving or using machines

Be careful before you drive or use any machines or tools until you know how Pethidine Juno affects you.

Pethidine may cause drowsiness and impairment of coordination in some people. Do not drive a car, operate machinery, or do anything else that could be dangerous if you are drowsy or feeling uncoordinated.

Drinking alcohol

Tell your doctor if you drink alcohol.

You must not drink alcohol while using pethidine. Do not drink alcohol while you are undergoing treatment with pethidine unless otherwise advised by your doctor or pharmacist, as drowsiness and coordination impairment may be worse.

Looking after your medicine

If you are being given Pethidine Juno while in hospital, it will be stored in the pharmacy or on the ward.

Pethidine Juno should be stored in a cool dry place, protected from light, where the temperature stays below 25°C.

Do not store it:

  • in the bathroom or near a sink, or
  • in the car or on window sills.

Keep it where young children cannot reach it.

When to discard your medicine (as relevant)

Do not use this medicine after the expiry date.

Pethidine Juno should not be given to you if the packaging is torn or shows signs of tampering.

Getting rid of any unwanted medicine

If you no longer need to use this medicine or it is out of date, take it to any pharmacy for safe disposal.

Do not use this medicine after the expiry date.

6. Are there any side effects?

All medicines can have side effects. If you do experience any side effects, most of them are minor and temporary. However, some side effects may need medical attention.

If you are over 65 years of age you may have an increased chance of getting side effects.

See the information below and, if you need to, ask your doctor or pharmacist if you have any further questions about side effects.

If you get any side effects, do not stop pethidine without first talking to your doctor or pharmacist.

Common side effects

Common side effectsWhat to do
  • drowsiness
  • dizziness or unsteadiness
  • disorientation
  • light-headedness
  • sweating or flushing
  • nausea and/or vomiting
  • constipation
  • hallucinations
  • pain and irritation at the injection site
  • blurred vision
  • dry mouth
  • mood changes
Speak to your doctor if you have any of these less common side effects and they worry you.
Mostly these are mild and short lived.

Serious side effects

Serious side effectsWhat to do
  • severe drowsiness
  • slow or rapid heart beat
  • difficulty in urinating
  • slow or troubled breathing
  • severe weakness
  • agitation
  • twitching
  • jerking
  • seizures (fits)
  • unconsciousness
  • itchy rash
Call your doctor straight away, or go straight to the Emergency Department at your nearest hospital if you notice any of these serious side effects.
You may need urgent medical attention or hospitalization.

Tell your doctor or pharmacist if you notice anything else that may be making you feel unwell.

Other side effects not listed here may occur in some people.

Reporting side effects

After you have received medical advice for any side effects you experience, you can report side effects to the Therapeutic Goods Administration online at www.tga.gov.au/reporting-problems. By reporting side effects, you can help provide more information on the safety of this medicine.

Always make sure you speak to your doctor or pharmacist before you decide to stop taking any of your medicines.

7. Product details

This medicine is only available with a doctor's prescription.

What Pethidine Juno contains

Active ingredient
(main ingredient)
Pethidine hydrochloride
Other ingredients
(inactive ingredients)
Sodium hydroxide
Hydrochloric Acid
Water for Injections

Do not use this medicine if you are allergic to any of these ingredients.

Pethidine Juno does not contain lactose, sucrose, gluten, tartrazine or any other azo dyes.

What Pethidine Juno looks like

Pethidine Juno is a clear, colourless, sterile solution in ampoules.

It is available in the following strength:

  • 100 mg/2 mL AUST R 340377

Who distributes Pethidine Juno

Juno Pharmaceuticals Pty Ltd
42 Kelso Street,
Cremorne,
VIC – 3121

This leaflet was prepared in June 2023.

Published by MIMS August 2023

BRAND INFORMATION

Brand name

Pethidine Juno

Active ingredient

Pethidine hydrochloride

Schedule

S8

 

Boxed Warnings

Limitations of use. Because of the risks associated with the use of opioids, pethidine should only be used in patients for whom other treatment options, including non-opioid analgesics, are ineffective, not tolerated or otherwise inadequate to provide appropriate management of pain (see Section 4.4 Special Warnings and Precautions for Use).
Hazardous and harmful use. Pethidine poses risks of hazardous and harmful use which can lead to overdose and death. Assess the patient's risk of hazardous and harmful use before prescribing and monitor the patient regularly during treatment (see Section 4.4 Special Warnings and Precautions for Use).
Life threatening respiratory depression. Serious, life-threatening or fatal respiratory depression may occur with the use of pethidine. Be aware of situations which increase the risk of respiratory depression, modify dosing in patients at risk and monitor patients closely, especially on initiation or following a dose increase (see Section 4.4 Special Warnings and Precautions for Use).
Concomitant use of benzodiazepines and other central nervous system (CNS) depressants, including alcohol. Concomitant use of opioids with benzodiazepines, gabapentinoids, antihistamines, tricyclic antidepressants, antipsychotics, cannabis or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Limit dosages and durations to the minimum required; and monitor patients for signs and symptoms of respiratory depression and sedation. Caution patients not to drink alcohol while taking pethidine.

1 Name of Medicine

Pethidine hydrochloride.

2 Qualitative and Quantitative Composition

2 mL sterile solution of pH 3.5 - 6.0 containing 100 mg of pethidine hydrochloride (50 mg/mL).
Excipients with known effect. None.
For the full list of excipients, see Section 6.1.

3 Pharmaceutical Form

Injection solution. Clear, colourless solution.

4 Clinical Particulars

4.9 Overdose

For information on the management of overdose, contact the Poisons Information Centre on 13 11 26 (Australia).
Symptoms. Overdosage is characterised by respiratory depression which may progress to Cheyne-Stokes respiration and/or cyanosis. Concomitant CNS depression may be present, as may extreme somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin and/or hypothermia, bradycardia and hypotension.
In severe overdosage, particularly following rapid intravenous administration, apnoea, circulatory collapse, cardiac arrest, respiratory arrest and death may occur.
Complications such as pneumonia, shock and/or pulmonary oedema may also prove fatal.
Overdosage of pethidine may produce mydriasis rather than miosis (pupillary constriction). Toxic effects of pethidine may be excitatory, especially in patients who have developed tolerance to the depressant effects of the drug. These patients may exhibit dry mouth, increased muscular activity, muscle tremors and twitches, tachycardia, delirium with disorientation, hallucinations and, occasionally, grand mal seizures.
Treatment. Since respiratory arrest may result either through direct depression of the respiratory centre or as the result of hypoxia, primary attention should be given to the establishment of adequate respiratory exchange through provision of a patent airway and institution of assisted or controlled ventilation.
The opioid antagonist, naloxone, is a specific antidote. Naloxone (see package information for full information) should be administered intravenously, simultaneously with respiratory resuscitation. As the duration of effect of naloxone may be considerably shorter than that of pethidine repeated administration may be necessary.
Note. The administration of the usual dose of opioid antagonist to a patient who is physically dependent on opioids will precipitate an acute withdrawal syndrome, the severity of which will depend on the degree of physical dependence and the dose of antagonist administered. If serious respiratory depression requiring treatment occurs in a patient who is physically dependent on opioids, an opioid antagonist should be administered with extreme care at a dose of 10 - 20% of the usual initial dose.

5 Pharmacological Properties

5.3 Preclinical Safety Data

Genotoxicity. No data available.
Carcinogenicity. No data available.

6 Pharmaceutical Particulars

6.7 Physicochemical Properties

Chemical structure.
https://stagingapi.mims.com/au/public/v2/images/fullchemgif/CSPETHYD.gif CAS number. 50-13-5.
The chemical name for pethidine hydrochloride is ethyl 1-methyl-4-phenylpiperidine-4-carboxylate hydrochloride. Empirical formula C15H21NO2.HCl. MW: 283.8.

7 Medicine Schedule (Poisons Standard)

Controlled drug (Schedule 8).

Summary Table of Changes

https://stagingapi.mims.com/au/public/v2/images/fulltablegif/PETJUNST.gif